What is the Retatrutide + Cagrilintide blend?

Retatrutide + Cagrilintide is a co-formulated blend pairing the triple agonist Retatrutide (5 mg) with the amylin analog Cagrilintide (5 mg), supplied by Certiva as a lyophilized reference material for laboratory research use only. It is not for human consumption.

Is a Certificate of Analysis provided?

Yes. Every batch ships with an independent, third-party Certificate of Analysis reporting HPLC purity (typically ≥ 99% per batch COA) and identity confirmation. Request the current batch COA together with your inquiry.

What specifications and quantities are available?

This blend is supplied at 10 mg per vial (5 mg Retatrutide + 5 mg Cagrilintide), 10 vials per box. Bulk and custom quantities are available on inquiry. No public pricing — we reply with a COA and quote within one business day.

How should the blend be stored?

The lyophilized Retatrutide + Cagrilintide blend is stored cold (typically -20°C), kept dry and away from light. Reconstituted material is kept refrigerated and used within its tested window; full handling notes accompany each order.

Retatrutide + Cagrilintide — Peptides Information

Retatrutide + Cagrilintide — Certiva Peptides

A co-formulated research blend of retatrutide and cagrilintide, supplied lyophilized as a reference.

Also known as: co-formulated blend

Configure your inquiry

Specification10 mg (5 mg + 5 mg)

Quantity

boxes

Ask on WhatsApp → Email inquiry ↓

No pricing online — we reply with a batch COA and quote within one business day.

Presentation	10 vials per box
Format	Lyophilized powder
Testing	Third-party HPLC + mass spectrometry, COA per batch
Use	For research use only

Composition

Retatrutide	5 mg
Cagrilintide	5 mg

For research use only. No medical, therapeutic, or dosing claims.

Working with concentration or unit conversions? Use the peptide reconstitution calculator for transparent mg, mcg, mL and U-100 arithmetic.

Prefer to leave your details? Send an inquiry form ↓ · See our COA process

Research applications

Combination incretin and amylin research models
Body-composition and appetite-signalling studies
Metabolic-regulation and energy-balance research
Comparative studies against single-agonist reference peptides

Listed for research context only — Certiva makes no medical, therapeutic, or dosing claims.

Who we supply

Peptide distributors and international resellers
Research laboratories and universities
Wellness and longevity clinics
Aesthetic clinics and cosmetic procurement teams
Fitness and performance professionals

Frequently asked questions

What is the Retatrutide + Cagrilintide blend?: Retatrutide + Cagrilintide is a co-formulated blend pairing the triple agonist Retatrutide (5 mg) with the amylin analog Cagrilintide (5 mg), supplied by Certiva as a lyophilized reference material for laboratory research use only. It is not for human consumption.
Is a Certificate of Analysis provided?: Yes. Every batch ships with an independent, third-party Certificate of Analysis reporting HPLC purity (typically ≥ 99% per batch COA) and identity confirmation. Request the current batch COA together with your inquiry.
What specifications and quantities are available?: This blend is supplied at 10 mg per vial (5 mg Retatrutide + 5 mg Cagrilintide), 10 vials per box. Bulk and custom quantities are available on inquiry. No public pricing — we reply with a COA and quote within one business day.
How should the blend be stored?: The lyophilized Retatrutide + Cagrilintide blend is stored cold (typically -20°C), kept dry and away from light. Reconstituted material is kept refrigerated and used within its tested window; full handling notes accompany each order.